COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
Ivermectin meta
1/19 Meta
Hill et al., Research Square, doi:10.21203/rs.3.rs-148845/v1 (Preprint) (meta analysis)
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
Source   PDF   Share   Tweet
Meta analysis of 18 ivermectin RCTs with 2,282 patients showing faster viral clearance (dose and duration dependent), improved clinical recovery, and lower hospitalization and mortality. In six RCTs of moderate or severe infection, there was a 75% reduction in mortality, RR 0.25 [0.12-0.52], p = 0.0002.

Hill et al., 1/19/2021, preprint, 40 authors.
Details of all 65 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit